Kim C. Ohaegbulam
- Oncology top 2%
- Immunology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Co-authors
- Xingxing ZangÉlodie PicardaAmer AssalYu YaoEszter Lázár‐MolnárHyungjun JeonJordan M. ChinaiRuihua Zhao
- Topics
- Cancer Immunotherapy and Biomarkers (10 papers)Immunotherapy and Immune Responses (7 papers)Immune cells in cancer (4 papers)
- Cited by
- OncologyImmunologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesNature CommunicationsJournal of Clinical Oncology
- Partner nations
- United StatesChinaCanada
In The Last Decade
Kim C. Ohaegbulam
18 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 1.2k
- Immunology 884
- Molecular Biology 416
- Pulmonary and Respiratory Medicine 339
- Cancer Research 180
Countries citing papers authored by Kim C. Ohaegbulam
This map shows the geographic impact of Kim C. Ohaegbulam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim C. Ohaegbulam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim C. Ohaegbulam more than expected).
Fields of papers citing papers by Kim C. Ohaegbulam
This network shows the impact of papers produced by Kim C. Ohaegbulam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim C. Ohaegbulam. The network helps show where Kim C. Ohaegbulam may publish in the future.
Co-authorship network of co-authors of Kim C. Ohaegbulam
This figure shows the co-authorship network connecting the top 25 collaborators of Kim C. Ohaegbulam. A scholar is included among the top collaborators of Kim C. Ohaegbulam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim C. Ohaegbulam. Kim C. Ohaegbulam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 33 | |
| 4 | 17 | |
| 5 | 18 | |
| 6 | 74 | |
| 7 | 5 | |
| 8 | 2 | |
| 9 | 38 | |
| 10 | 21 | |
| 11 | Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapybreakdown → | 402 |
| 12 | 78 | |
| 13 | 131 | |
| 14 | 8 | |
| 15 | Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathwaybreakdown → | 654 |
| 16 | 60 | |
| 17 | 21 | |
| 18 | 166 | |
| 19 | 56 |
About Kim C. Ohaegbulam
Kim C. Ohaegbulam is a scholar working on Immunology, Oncology and Otorhinolaryngology, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (7 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (884 citations) and Cancer Research (180 citations). Kim C. Ohaegbulam has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Xingxing Zang, Élodie Picarda, Amer Assal, Yu Yao, Eszter Lázár‐Molnár, Hyungjun Jeon, Jordan M. Chinai, Ruihua Zhao, Aimin Zhao and Lisa Scandiuzzi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.